Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.
about
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic LeFLT3 and NPM-1 mutations in a cohort of acute promyelocytic leukemia patients from IndiaDoes microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA GroupArsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARATreatment of acute promyelocytic leukemia with single-agent arsenic trioxide.Molecular characteristics and chromatin texture features in acute promyelocytic leukemia.Clinical and pathologic features of secondary acute promyelocytic leukemia.Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivo.Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia.Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia.Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.FLT3-ITD and its current role in acute myeloid leukaemia.Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia.PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.Acute promyelocytic leukemia harbouring rare FLT3-TKD and WT1 mutations: A case report.Prognostic significance of the FLT3 ITD mutation in patients with normal-karyotype acute myeloid leukemia in relapse.FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis.The Impact of FLT3 Mutations on the Development of Acute Myeloid Leukemias.Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocytic leukemia cells.Early mortality in acute promyelocytic leukemia: Potential predictors.The level of peripheral blood circulating CD34+ cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors.The novel three-way variant t(6;17;15)(p21;q21;q22) in acute promyelocytic leukemia with an FLT3-ITD mutation: A case report
P2860
Q27853031-E7FA23F0-4AA2-44DC-98FD-07A6B6CEB3D8Q34494573-0FCB00C2-EA28-43D1-8456-1605E38BC813Q34541742-035D46DC-07AF-4C77-BCE1-87A1D03825EFQ34754867-85C6CBDC-7F9E-407E-8F17-DDDA30A14070Q35265901-2B1AC43F-A3AE-4F5E-976B-9D74610A3105Q35596919-A68AF788-EC6B-455A-B50E-F8FE7A8579CEQ35640744-E4DC9882-6BAC-4AB5-A178-31ED48A98331Q36338616-2B286584-A834-49B5-A9C3-ECB6F03E6D75Q36627692-51CD7BD1-AF89-431C-81AE-B235ACE95ED3Q36823385-F0679854-7747-43C1-B169-B384DD8175F9Q37212864-A8A4785A-5B4A-4D05-B6E2-25C948F8EAF4Q37718455-862B13B1-45C1-493D-8057-F39768F6651EQ38752325-B4CA5E8C-98D6-4FF0-9406-272B3C2E25F4Q39282600-6389C645-3E35-4BFE-AC5A-908F55ECF0A8Q39601375-9211485A-0AB7-4701-BD49-C2F8FEFF9BE8Q39805430-8F745624-7B3E-4313-B92C-66F80DB6C99EQ42271164-AE6B64C7-CBDB-42C0-89A4-EDA933CDDE0EQ42785026-AC5A2428-AE63-42F1-A0F1-0D339FC8EF1DQ42831333-8D662316-E3B7-4A89-849B-8DDB8DC71822Q43070849-A67D4EA3-090F-4119-83E6-BC99314FC871Q51075745-65D535C0-52E9-4E75-8DF6-73ABE9D5A4FBQ52355167-8E537D5D-C914-4647-AFB4-EF8991DD30EFQ53142140-4C3D4C98-7437-4CF2-89A0-F5C6C7DA5578Q57788688-53DED783-5381-4CCC-9E80-23D664E27A9D
P2860
Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long FLT3 internal tandem dupl ...... omyelocytic leukemia patients.
@ast
Long FLT3 internal tandem dupl ...... omyelocytic leukemia patients.
@en
type
label
Long FLT3 internal tandem dupl ...... omyelocytic leukemia patients.
@ast
Long FLT3 internal tandem dupl ...... omyelocytic leukemia patients.
@en
prefLabel
Long FLT3 internal tandem dupl ...... omyelocytic leukemia patients.
@ast
Long FLT3 internal tandem dupl ...... omyelocytic leukemia patients.
@en
P2093
P2860
P1433
P1476
Long FLT3 internal tandem dupl ...... omyelocytic leukemia patients.
@en
P2093
Alfonso García de Coca
Ana Balanzategui
Carlos Santamaría
Fernando Ramos
Jesús F San Miguel
Joaquín Díaz-Mediavilla
José Antonio Queizán
Luis Marín
Marcos González
María Belén Vidriales
P2860
P304
P356
10.3324/HAEMATOL.2009.015073
P577
2010-02-04T00:00:00Z